Summary

Eligibility
for people ages 18-75 (full criteria)
Dates
study started
completion around
Principal Investigator
by Satoshi Tateshima, MD (ucla)
Headshot of Satoshi Tateshima
Satoshi Tateshima

Description

Summary

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

Official Title

COGNITIVE Study- Cognition and Imaging With Tigertriever

Keywords

Stroke

Eligibility

You can join if…

Open to people ages 18-75

  1. Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as indicated per the approved IFU.
  2. Tigertriever was used as the first line treatment in the target vessel.
  3. A signed informed consent.
  4. Age 18-75 years (inclusive).
  5. No known significant pre-stroke disability (pre-stroke mRS 0 or 1).

You CAN'T join if...

  1. Use of any other IA recanalization device prior to the Tigertriever in the target vessel, including aspiration catheter.
  2. Evidence of acute brain hemorrhage on CT and/or MRI at admission.
  3. Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months.
  4. Probable cerebral amyloid angiopathy.
  5. Pre-stroke diagnosed dementia and/or prescribed cholinesterase inhibitors.
  6. Pre-stroke diagnosed and/or currently treated major depression.
  7. Pre-stroke learning or intellectual disability.
  8. Anticipated inability to obtain 6-month follow-up assessments.

    -

Lead Scientist at University of California Health

  • Satoshi Tateshima, MD (ucla)
    HS Clinical Professor, Radiological Sciences, Medicine. Authored (or co-authored) 170 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Rapid Medical
ID
NCT05531461
Study Type
Observational [Patient Registry]
Participants
Expecting 424 study participants
Last Updated